Fetal Monitoring Market - By Product (Ultrasound Devices, Electronic Fetal Monitoring, Uterine Contraction Monitor, Accessories and Consumables), By Portability (Portable, Non-portable), By Method (Invasive, Non-invasive), By End-use – Global Forecast, 2023-2032

Fetal Monitoring Market - By Product (Ultrasound Devices, Electronic Fetal Monitoring, Uterine Contraction Monitor, Accessories and Consumables), By Portability (Portable, Non-portable), By Method (Invasive, Non-invasive), By End-use – Global Forecast, 2023-2032

Fetal Monitoring Market Size

Fetal Monitoring Market size was valued at USD 5.1 billion in 2022 and is estimated to account for USD 9.7 billion by 2032.

Fetal monitoring is a medical procedure and diagnostic technique used during pregnancy to monitor and assess the well-being and vital signs of a developing fetus. It involves the continuous or periodic measurement and recording of key fetal parameters such as the fetal heart rate and uterine contractions to ensure the baby's health and detect any signs of distress or abnormalities. Moreover, this monitoring assists healthcare providers in making informed decisions about pregnancy management and ensuring a safe childbirth process.

Furthermore, the fetal monitoring market is growing due to rising pregnancy-related complications, technological advancements in monitoring devices, government initiatives for maternal and child health, increased adoption of non-invasive devices, and a surge in preterm births and infertility treatments. These above-mentioned factors are anticipated to accelerate the vital role of fetal monitoring in ensuring safe pregnancies and childbirth.

The increasing occurrence of pregnancy-related complications, such as gestational diabetes, preeclampsia, and placental abnormalities is fueling the demand for market. For instance, according to the World Health Organization (WHO), preeclampsia impacts 2% to 10% of pregnancies globally, with a higher incidence of 1.8% to 16.7% in developing countries compared to the lower rate of 0.4% in developed nations.

Additionally, as per the Centers for Disease Control and Prevention (CDC), the diagnosis rate of gestational diabetes among mothers giving birth increased from 6.0% in 2016 to 8.3% in 2021. Therefore, these complications can have adverse effects on both the mother and the fetus. Continuous fetal monitoring helps healthcare providers detect and manage these complications in a timely manner, improving the chances of a safe pregnancy and delivery thereby bolstering market growth potential.

COVID-19 Impact

The COVID-19 pandemic initially disrupted various aspects of healthcare, including maternal and fetal monitoring, as healthcare systems grappled with the crisis. However, there emerged an overall positive impact as the pandemic unfolded. The adoption of telemedicine and remote patient monitoring technologies accelerated, enabling expectant mothers to receive prenatal care and fetal monitoring from the safety of their homes.

Furthermore, innovations in medical devices and diagnostics were spurred by the urgency of the pandemic, benefiting fetal monitoring technologies. Additionally, increased research and awareness about the effects of COVID-19 on pregnancy led to improved guidelines and understanding. Moreover, healthcare systems adapted to ensure the safety of expectant mothers and infants, demonstrating resilience in the face of challenges. Therefore, these developments positively contributed to maternal and fetal health monitoring, although the pandemic persisted.

Fetal Monitoring Market Trends

Several governments and healthcare organizations worldwide have launched initiatives and programs to improve maternal and child health. For instance, as per the U.S. Department of Health and Human Services, the Maternal, Infant, and Child Health Workgroup, operating within the Healthy People 2030 initiative, strives to diminish disease and mortality rates among women, infants, and children. Its key objectives encompass the reduction of complications during pregnancy, enhancement of healthcare accessibility and quality, advocacy for healthy lifestyle choices, and the rectification of healthcare disparities. Such government initiatives and funding contribute to the expansion of the market

Furthermore, the global increase in preterm births, often associated with the need for close fetal monitoring, is a significant driver for the market. Moreover, those survived often grappled with lifelong disabilities, including learning difficulties and sensory impairments. Therefore, fetal monitoring aids in addressing preterm birth challenges by enabling early detection, guiding interventions, and optimizing neonatal care. Additionally, as more couples seek infertility treatment and assisted reproductive technologies, the need for fetal monitoring during pregnancy and childbirth increases, further boosting market demand.

Fetal Monitoring Market Analysis

The fetal monitoring market by product type is categorized into ultrasound devices, electronic fetal monitoring (EFM), uterine contraction monitor, accessories and consumables, and others. The ultrasound devices segment is further divided into 2D ultrasound, 3D and 4D ultrasound, and doppler imaging. Furthermore, the electronic fetal monitoring (EFM) segment is further bifurcated into external EFM and internal EFM.

The ultrasound devices segment garnered over USD 2.7 billion revenue size in the year 2022. The dominance of the segment can be attributed to its remarkable accuracy, versatility, and safety. Ultrasound technology provides real-time visualization of the fetus, monitors heart rates, and assesses movements with precision, making it a preferred choice for healthcare providers. Furthermore, its non-invasive nature ensures the safety of both the mother and the fetus, while early detection of abnormalities and complications facilitates timely interventions.

Moreover, ultrasound's clinical utility spans routine check-ups to high-risk pregnancies, enhancing its indispensability. Continuous technological advancements, including 2D, 3D, and 4D ultrasound, further solidify its position as the dominant and preferred tool for fetal monitoring.

Based on portability, the fetal monitoring market is segmented into portable and non-portable. The portable segment is predicted to grow at 6.8% CAGR over the analysis timeframe. Portable fetal monitoring devices excel in accessibility and mobility, enabling healthcare providers to perform assessments in various settings, including patients' homes and outpatient clinics. This flexibility enhances patient convenience by reducing the need for frequent facility visits, making prenatal care more accessible and convenient
 

Moreover, these devices facilitate remote monitoring, enabling healthcare providers to track fetal health from a distance, a crucial feature during the COVID-19 pandemic. Additionally, portable devices offer cost-effective solutions for healthcare facilities and continue to evolve with technological advancements, enhancing their efficiency and user-friendliness, thereby solidifying their dominance in the market.

Based on method, the fetal monitoring market is segmented into invasive and non-invasive. The non-invasive segment dominated the market and accounted for more than 75% market share in the year 2022 and is anticipated to witness the highest growth during the forecast period. Non-invasive methods such as external electronic fetal monitoring (EFM) offer a safe and comfortable monitoring experience for expectant mothers, eliminating the need for invasive procedures and the associated discomfort and risks.

Furthermore, non-invasive methods stand out for their ability to minimize the risk of infection, a critical consideration during pregnancy. Moreover, these methods are widely adopted as the standard for routine prenatal care, facilitating their widespread use in healthcare settintheirhere user-friendly technology and cost-effectiveness make them an economically viable choice for healthcare facilities. Therefore, these combined attributes have solidified the non-invasive segment's dominance in the market, positioning it as the preferred method for monitoring fetal well-being during pregnancy.

The fetal monitoring market by end-use is categorized into hospitals, specialty clinics, and others. The hospital segment is estimated to grow substantially to reach over USD 5.2 billion revenue size by the end of 2032. The dominance of the segment can be attributed to its clinical expertise, advanced infrastructure, and emergency response capabilities. Hospitals offer comprehensive maternity care, ensuring continuous fetal monitoring from pregnancy to childbirth. Hospital settings are specialized in high-risk cases and have a strong foundation of patient trust. Additionally, their involvement in research and training contributes to the development of monitoring techniques and technologies, consolidating their position as the preferred choice for fetal monitoring during childbirth.

U.S. fetal monitoring market accounted for USD 1.8 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. The advanced healthcare infrastructure of the U.S., characterized by well-equipped facilities, fosters the widespread adoption of fetal monitoring practices. For instance, as per the report of Centers for Disease Control and Prevention (CDC), gestational diabetes impacts 2% to 10% of pregnancies each year in the U.S. Therefore, the increasing prevalence of gestational diabetes in the U.S. has led to a greater emphasis on fetal monitoring to manage potential risks and complications associated with this condition.

Furthermore, the U.S. maintains a leading position in technological advancements, continually developing and deploying cutting-edge fetal monitoring devices and techniques. Additionally, ongoing research and development efforts drive innovation in the field, while comprehensive healthcare insurance coverage encourages expectant mothers to prioritize regular prenatal care and fetal monitoring. These factors collectively propel the market and emphasize the significance of fetal monitoring in ensuring healthy pregnancies and childbirth in the U.S.

Fetal Monitoring Market Share

Some of the eminent market participants operating in the fetal monitoring market include

• Cardinal Health Inc.
• MedGyn products, inc.
• EDAN Instrument, Inc.
• Natus Medical Incorporated.
• Koninklijke Philips N.V.
• General Electric Company
• FUJIFILM Holdings Corporation
• Siemens AG
• Neoventa Medical AB
• Huntleigh Healthcare (Arjo)
• BD (Becton, Dickinson, and Company)
• Medtronic plc
• Spacelabs Healthcare

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Company Market Share Analysis

Within the fetal monitoring market, numerous large companies compete to offer cost-effective alternatives to new fetal monitoring devices. Analysing market share involves identifying and evaluating the many players that manufacture and sell the devices. It is a mosaic of diverse providers contending for the attention of hospitals and clinics seeking to optimize their budgets without compromising on quality.
 

For instance, Koninklijke Philips N.V., Medtronic plc, Siemens Healthineers, and Fujifilm Sonosite account for approximately 45% share in the overall fetal monitoring industry. Philips is known to invest heavily in research and development in order to develop advanced fetal monitoring technologies focused towards enhancing the ease of use and accuracy of monitoring systems.
 

Fetal Monitoring Industry News

• In June 2023, Neoventa Medical AB partnered with YMS, a distributor and reseller of various medical supplies, to offer advanced fetal monitoring solutions tailored to the unique needs of healthcare providers in South Africa. Such partnerships and collaborations augment industry expansion.
   
• In May 2023, Cardinal Health Canada revealed its intention to establish a new distribution center in the Greater Toronto Area (GTA), thus expanding its distribution network to nine strategically positioned locations. This expansion aims to enhance the company's ability to meet the growing demands for medical and surgical products within the Canadian healthcare system.
   

Fetal monitoring market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in Units from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product (USD Million & Units)

• Ultrasound devices 
• 2D ultrasound
• 3D and 4D ultrasound
• Doppler imaging 
• Electronic fetal monitoring (EFM) 
• External EFM
• Internal EFM 
• Uterine contraction monitor
• Accessories and consumables
• Others

By Portability (USD Million)

• Portable
• Non-portable

By Method (USD Million)

• Invasive
• Non-invasive

By End-use (USD Million)

• Hospitals
• Specialty clinics
• Others

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • The Netherlands
  • Russia
  • Poland
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel